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Fever in a returned traveller may be the manifestation of a self-limiting, trivial infection but it can also presage an infection that
can be rapidly progressive and lethal. We studied the diagnostic accuracy of procalcitonin (PCT) as a biomarker for a bacterial
cause of fever in a cohort of 157 consecutive travellers with fever after a stay in the (sub)tropics. Elevated procalcitonin levels were
observed not only in about 50% of travellers with proven bacterial infection, but also in a signiﬁcant proportion of travellers with
a likely infection. Using a cutoﬀ point of 0.5ng/mL, procalcitonin had a sensitivity of 0.52 and a speciﬁcity of 0.76 for a bacterial
cause of fever on admission. Interestingly, only 1 out of 16 patients with a proven viral infection had a marginally elevated PCT
concentration on admission, suggesting that an increased PCT level likely excludes a viral infection as the cause of fever. However,
thediagnosticaccuracyofthissemiquantitativeprocalcitonintestforabacterialcauseoffeveronadmissionistoopoortoadvocate
its use in the initial clinical evaluation of fever in a setting of ill-returned travellers.
Copyright © 2009 Dennis A. Hesselink et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Background
While fever in a returned traveller may be the manifestation
of a self-limiting, trivial infection, it can also presage an
infection that can be rapidly progressive and lethal. Initial
attention should focus most urgently on infections that
are treatable and transmissible and that may cause serious
sequelae or even death. International travel expands the
list of potential infections that must be considered in
returning travellers [1]. Malaria is probably the most feared
infectious disease to consider in anyone who returns with
feveraftervisitingantropicalarea,necessitatinginvestigation
without delay [1]. After exclusion of malaria, the clinician
must subsequently decide whether the imminent threat of
the infection is likely to be caused by bacteria or viruses
and whether the feverish patient should be admitted for
intensiﬁed treatment including empirical treatment with
antibiotics.
Procalcitonin (PCT), a precursor peptide from the
hormone calcitonin, has been considered by some to be a
speciﬁcandusefulindicatorofinvasiveinfectionsbybacteria
[2]. Under normal metabolic conditions, hormonally active
calcitonin is produced and secreted in the C-cells of the
thyroid gland through a regulated pathway after procession
of the prohormone PCT [3]. Thus, under normal condi-
tions, PCT levels in the circulation are very low (usually
<0.05ng/mL). Interestingly, in case of severe bacterial infec-
tions, microbial products (e.g., LPS) and proinﬂammatory
mediators of the host response (e.g., Tumor Necrosis Factor
α and Interleukin-1β) result in a generalized tissuewide
induction of calcitonin mRNA and a consequent secretion
of calcitonin precursors including unprocessed PCT through2 Interdisciplinary Perspectives on Infectious Diseases
a nonregulated constitutive pathway [3]. As a result, PCT is
released from all parenchymal tissues and diﬀerentiated cell
types throughout the body, resulting in signiﬁcant elevations
of PCT levels in the circulation [3]. Moreover, Interferon-
gamma inhibits IL-1β-induced calcitonin mRNA expression
and PCT secretion, which may explain why circulating PCT
levels tend to remain unchanged in viral infections [3].
In several clinical studies involving selected groups of
patients with lower respiratory tract infections, pneumonia,
acute exacerbations of chronic obstructive lung disease, and
septic patients, respectively, antibiotic use was markedly
diminished and prescribed shorter when treatment was
guided by an ultrasensitive PCT assay [2, 4–6]. Apart from
its surplus value in treatment algorithms, PCT may probably
also contribute to an early diagnosis of bacterial infections
in certain patient groups. We evaluated the diagnostic
accuracy of PCT for bacterial infections in the initial clinical
assessment of travellers, who returned home with fever after
a stay in the (sub)tropics.
2. Methods
The Harbour Hospital is a 161-bed general hospital located
in Rotterdam, The Netherlands. It also harbours the Institute
of Tropical Diseases which serves as a national referral
centre for tropical diseases. All travellers who presented
with a documented fever on admission, were eligible for
enrolment in this observational study. Fever was deﬁned
as a body temperature of ≥38.5◦C. Since in our clinical
practicemalariaisruledoutﬁrstinpatientswhopresentwith
fever after a stay in the (sub)tropics, patients with malaria
were excluded from this study. All laboratory measurements
were performed using standard laboratory techniques. PCT
was measured with the BRAHMS PCT-Q test (Brahms
Diagnostics, Germany) according to the instructions of
the manufacturer [7]. This immunochromatographic test
allows a semiquantitative detection of PCT. It is designed
as a point-of-care test for the rapid and easy measurement
of PCT. Using this assay, an early laboratory-independent
measurement of PCT on serum or plasma is possible within
30 minutes. PCT-Q results were classiﬁed as follows: a
negative result or a PCT < 0.5ng/mL was classiﬁed as
“normal”; a PCT of 0.5ng/mL or a PCT between 0.5–
2.0ng/mL was classiﬁed as “low”; a PCT of 2.0ng/mL or a
PCT between 2.0–10.0 was classiﬁed as “moderate”; a PCT of
10.0ng/mL and above 10ng/mL was classiﬁed as “high”a s
recommended [8].
Demographic, clinical, and laboratory data on admission
were collected for each traveller. The outcome of the
patient was determined by two investigators (H.B.T and
P.J.v.G) after careful review of patient records. Outcome
was classiﬁed as follows: “infection proven” for those out-
comes in which the causative micro-organism was either
cultured or a seroconversion was documented or in case
of a pathognomonical clinical presentation (e.g., a creeping
eruption); outcomes in which a speciﬁc micro-organism
could not be demonstrated, but the clinical course suggested
an infectious cause were classiﬁed as “infection likely.” These
presumptive diagnoses were based on epidemiologic and
clinical features, supporting laboratory investigations, and
a response to appropriate treatment. In case no infectious
cause could be found (usually after extensive investigations)
or an alternative diagnosis was made, the outcomes were
classiﬁed as “no infection.” In those travellers in which
the outcome was classiﬁed as “infection proven” subgroups
were made depending on the class of the causative micro-
organisms, that is, viral, bacterial, or parasitic. Finally, of
each traveller, the PCT level on admission was related to
these predeﬁned outcomes, and sensitivity analyses of PCT
for bacterial infections were performed using diﬀerent cutoﬀ
levels of PCT.
2.1. Statistical Analysis. All values are presented as median
(range). For comparison between groups, the Kruskal-Wallis
testwasusedasappropriate.Posthocanalysiswasperformed
using Mann-Whitney U test. P values at α<. 05 were
considered statistically signiﬁcant.
3. Results
In the period January 2005 to December 2007 a total of 1260
travellers were screened for inclusion in this observational
study, as shown in Figure 1. In 201 of them fever was
documented on admission. Forty-four of these patients had
malaria and were excluded from this study according to
our clinical algorithm. When the 157 remaining patients
were allocated to the predeﬁned outcomes, an infectious
cause was demonstrated in 64 patients (group “infection
proven”), an infectious cause was considered likely in 88
patients(group“infectionlikely”),andacauseforfeverother
than an infection was demonstrated in 5 patients (group “no
infection”), respectively. The general characteristics of the
various patient groups on admission, grouped according to
their (predeﬁned) outcomes, are shown in Table 1.
3.1.PatientsGroupedas“InfectionProven”. Withinthegroup
“infection proven” a viral cause was demonstrated in 16
(dengue virus n = 8; Epstein Barr Virus n = 2; inﬂuenza
n = 2; rubella n = 1; other n = 3) travellers, 46 patients had
ab a c t e r i a lc a u s e( Salmonella n = 13; Streptococcal infection
n = 6; Rickettsia n = 4; Campylobacter n = 4; Shigella
n = 3; Staphylococcal infection n = 2; Leptospira n = 4;
Coxiella burneti n = 3; other n = 7), and parasitic cause was
demonstrated in 2 cases (Katayama syndrome due to acute
schistosomiasis in 1; visceral leishmaniasis in 1), respectively.
3.2. Patients Grouped as “Infection Likely”. In 88 patients
grouped as “infection likely” the clinical presentation and
subsequent course was highly suggestive of an infectious
cause but a causative micro-organism could not be demon-
strated (gastroenteritis n = 26; upper and lower respiratory
tract infections n = 21; unspeciﬁed febrile illness n = 17;
skin infection n = 4; urinary tract infections n = 4, other
n = 16), even after repeat cultures and serology.
3.3. Patients Grouped as “No Infection”. The group “no
infection” consisted of 5 patients in whom fever was relatedInterdisciplinary Perspectives on Infectious Diseases 3
Table 1: General and laboratory characteristics of the travellers with fever on admission, speciﬁed by outcome and class of causative micro-
organism. Data are given as median [range].
Infection proven (n = 64) Infection likely
(n = 88)
No infection
(n = 5) Viral infection
(n = 16)
Bacterial infection
(n = 46)
Parasitic infection
(n = 2)
Age (year) 27 [17–50] 30 [15–68] 30 [17–43] 40 [14–73] 40 [10–53]
Male/female 8/82 4 /22 1/15 7 /31 1/4
Continent of acquisition (n [%])
Europe 1[ 6 .3] 1 [2.2] 0 4 [4.5] 0
Americas 6[ 3 7 .5] 9 [19.6] 0 10 [11.4] 1 [20.0]
Africa 2[ 1 2 .5] 10 [21.7] 1 [50.0] 31 [35.2] 4 [80.0]
Asia and Oceania 7[ 4 3 .8] 26 [56.5] 0 43 [48.9] 0
Unknown 001 [ 5 0 .0] 0 0
Presenting symptoms (n [%])
History of fever 13 [81.37] 45 [97.8] 2 [100] 84 [95.5] 4 [80.0]
Skin problems 5[ 3 1 .3] 1 0[ 2 1 .7] 0 12 [13.6] 0
Diarrhea 7[ 4 3 .8] 25 [54.3] 2 [100] 35 [39.8] 2 [40.0]
Shortness of breath 5[ 3 1 .3] 14 [30.4] 1 [50.0] 31 [35.2] 2 [40.0]
Headache 10 [62.5] 26 [56.5] 1 [50.0] 50 [56.8] 3 [60.0]
Muscle ache 6[ 3 7 .5] 18 [39.1] 1 [50.0] 35 [39.8] 1 [20.0]
Malaise 4[ 2 5 .0] 9 [19.6] 0 32 [36.4] 2 [40.0]
Nausea/vomiting 6[ 3 7 .5] 16 [34.8] 1 [50.0] 25 [28.4] 0
Others 8[ 5 0 .0] 7 [15.2] 0 22 [25.0] 2 [40.0]
Duration of complaints (n [%])
<8d a y s 13 [81.3] 3 4[ 7 3 .9] 2 [100] 71 [80.7] 2 [40.0]
8–14 days 2[ 1 2 .5] 7 [15.2] 0 9 [10.2] 1 [20.0]
15–28 days 02 [ 1 2 .5] 0 1 [1.1] 1 [20.0]
>29 days 1[ 6 .3] 3 [18.8] 0 7 [8.0] 1 [20.0]
Physical ﬁndings (median [range])
Temperature (
◦C) 39.1[ 3 8 .5–40.9] 39.3[ 3 8 .5–41.0] 39.2[ 3 8 .6–39.8] 39.2[ 3 8 .5–40.5] 38.7[ 3 8 .5–39.9]
Pulse (beats/minute) 100 [72–120] 104 [72–125] 122 [100–144] 93 [65–160] 94 [84–104]
Systolic blood pressure (mmHg) 120 [95–160] 120 [90–180] 133 [130–136] 126 [90–195] 115 [96–130]
Laboratory ﬁndings
ESR (mm/h) 10 [2–56] 23 [3–114] 38 21 [2–98] 28 [8–58]
Leukocytes (×109/L) 6.0[ 1 .9–14.2] 9.8[ 3 .3–18.9] 7.7[ 4 .4–11.0] 8.0[ 2 .6–23.2] 5.8[ 3 .3–7.4]
C-reactive protein (mg/mL) 13 [4–106] 76 [4–462] 102 [100–104] 56 [4–298] 9 [4–125]
to a noninfectious cause (inﬂammatory bowel disease n = 2;
auto immune disorder n = 3).
3.4. PCT Results on Admission. The majority (67.5%) of the
157patientswithfeverhadanormalPCTlevelonadmission.
Patients with fever caused by a viral infection or with a
noninfectious causeoffeverhadanormalPCTonadmission
in all but 1 patient. Moderate to high PCT levels were only
observedinpatientswithdocumentedbacterialandparasitic
infections and in about a quarter of the patients grouped
as “likely infection.” As shown in Figure 2 (left panel), in
patients with proven bacterial and viral cause of fever and
those with a likely infection, a signiﬁcant relation could be
established between body temperature on admission and
PCT levels, respectively. This correlation was most clear for
patients with a demonstrated bacterial cause of fever. This
relationship was not present for CRP and PCT levels on
admission, respectively (Figure 2 right panel).
3.5. Diagnostic Accuracy of PCT for a Bacterial Cause of
Fever on Admission. As detailed in Table 2(a), a PCT cutoﬀ
point of 0.5ng/mL resulted in a limited sensitivity and
speciﬁcity of 0.52 and 0.76, respectively. The positive and
negative predictive values of PCT for a bacterial cause of
fever were too low, with values of 0.47 and 0.79, respectively.
Increasingthecutoﬀlevelto2.0and10.0ng/mL,respectively,
increased the speciﬁcity but resulted in a dramatic drop of
sensitivity. The PPV of PCT (cutoﬀ point 0.5ng/mL) for a
conﬁrmed bacterial cause of fever would have increased to
0.94 if all patients with a likely infection were assumed to4 Interdisciplinary Perspectives on Infectious Diseases
1260 travellers included
Fever on admission (n = 201)
Malaria excluded (n = 44)
157 travellers remaining
Procalcitonin normal
(n = 106)
Procalcitonin elevated
(n = 51)
No infection
(n = 5)
Infection proven
(n = 37)
Infection likely
(n = 64)
No infection
(n = 0)
Infection proven
(n = 27)
No infection
(n = 24)
Viral (n = 15) Bacterial (n = 22) Parasitic (n =0) Viral (n = 1) Bacterial (n = 24) Parasitic (n =2)
Figure 1: Flow-chart of procalcitonin test results on admission in relation to a predeﬁned outcome in a cohort of 157 consecutive travellers
who presented with fever (i.e., a body temperature ≥38.5◦C on admission). An elevated procalcitonin level was deﬁned as a PCT level ≥
0.5ng/mL as measured with a semiquantitative assay.
Table 2
(a) Descriptive statistics of procalcitonin (PCT) as an admission biomarker for a conﬁrmed bacterial cause of fever in all 157 travellers. Data are given as
proportion [ 95% conﬁdence interval] .
PCT test Cutoﬀ 0.5ng /mL Cutoﬀ 2.0ng/mL Cutoﬀ 10ng/mL
Sensitivity 0.52 [0.37–0.67] 0.20 [0.10–0.34] 0.02 [0.00–0.13]
Speciﬁcity 0.76 [0.66–0.83] 0.91 [0.84–0.95] 0.97 [0.92–0.99]
Positive predictive value 0.47 [0.33–0.61] 0.47 [0.25–0.71] 0.25 [0.01–0.78]
Negative predictive value 0.79 [0.70–0.86] 0.73 [0.65–0.80] 0.71 [0.63–0.78]
(b) Descriptive statistics of procalcitonin (PCT) as an admission biomarker for a conﬁrmed bacterial cause of fever in all 157 travellers if all patients with a
likely infection (n = 88) were assumed to also have a conﬁrmed bacterial infection. Data are given as proportion [ 95% conﬁdence interval] .
PCT test Cutoﬀ 0.5ng /mL Cutoﬀ 2.0ng /mL Cutoﬀ 10ng /mL
Sensitivity 0.36 [0.28–0.45] 0.13 [0.08–0.20] 0.01 [0.00–0.06]
Speciﬁcity 0.87 [0.65–0.97] 0.91 [0.70–0.98] 0.91 [0.70–0.98]
Positive predictive value 0.94 [0.83–0.98] 0.89 [0.65–0.98] 0.50 [0.09–0.91]
Negative predictive value 0.19 [0.12–0.28] 0.15 [0.10–0.23] 0.14 [0.09–0.20]
have proven bacterial infection (Table 2(b)). In a receiver
operating characteristic (ROC) curve, PCT test appeared
onlysomewhatmoresensitiveforpredictingabacterialcause
of fever on admission than testing of C-reactive protein
(Figure 3).
3.6. Diagnostic Accuracy of PCT for a Positive Blood Culture
(Bacteremia) on Admission. In the group of patients with
a documented bacterial infection, blood cultures were per-
formed in 41 of 46 patients on admission. Increased PCT
levels on admission were signiﬁcantly (Fisher exact test,
P = .031) more frequently observed in bacteremic (i.e., a
positive blood culture) individuals (11 of 17 patients) than
in individuals with a negative blood culture on admission
(7 of 24 patients). As shown in Table 3, an increased PCT
level on admission had a sensitivity of 0.65 and PPV of 0.61
for bacteremia at a cutoﬀ point of 0.5ng/mL. Increasing the
cutoﬀ point to 2 and 10ng/mL dramatically aﬀected the
diagnostic performance of PCT test. For the whole cohort
of 157 travellers with fever—assuming that all other patients
had a negative blood culture on admission—an increased
PCT had a sensitivity of 0.65 and PPV of 0.22 for bacteremia,Interdisciplinary Perspectives on Infectious Diseases 5
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Figure 2: Left panel. Relationship between body temperature on admission and procalcitonin levels on admission. (a) Relationship in
patients with a documented viral cause of fever (n = 16). No statistical analysis performed. (c) Relationship in patients with a documented
bacterial cause of fever (n = 46). Overall, P-value <. 0001 (Kruskal Wallis), speciﬁed per PCT result: Normal versus Low P<. 0001 (Mann-
WhitneyUtest).NormalversusModerateP<0.0001 (Mann-WhitneyUtest),andLowversusModerateP = .0001(Mann-WhitneyUtest),
(e) Relationship in patients with a likely infection (n = 88). Overall, P-value <. 0001 (Kruskal Wallis), speciﬁed per PCT result: Normal
versus Low P<. 0001 (Mann-Whitney U test), Normal versus Moderate P<. 0001 (Mann-Whitney U test), Low versus Moderate P = .0003
(Mann-Whitney U test). Right panel. Relationship between C-reactive protein and procalcitonin levels on admission. (b) Relationship in
patients with a documented viral cause of fever (n = 16). No statistical analysis performed. (d) Relationship in patients with a documented
bacterial cause of fever (n = 46). Overall, P-value P = .12 (Kruskal-Wallis). (f) Relationship in patients with a likely infection (n = 88).
Overall, P-value .36 (Kruskal-Wallis).6 Interdisciplinary Perspectives on Infectious Diseases
Table 3: Descriptive statistics of procalcitonin (PCT) as an admission biomarker for bacteremia in 41 travellers who had a conﬁrmed
bacterial cause of fever and a blood-culture done on admission. Data are given as proportion [95% conﬁdence interval] .
PCT test Cutoﬀ 0.5ng /mL Cutoﬀ 2.0ng /mL Cutoﬀ 10ng /mL
Sensitivity 0.65 [0.39–0.85] 0.18 [0.05–0.44] 0.06 [0.00–0.31]
Speciﬁcity 0.71 [0.49–0.87] 0.92 [0.72–0.99] 1.00 [0.83 −1.00]
Positive predictive value 0.61 [0.36–0.82] 0.60 [0.17–0.93] 1.00 [0.05 −1.00]
Negative predictive value 0.74 [0.51–0.89] 0.61 [0.44–0.76] 0.60 [0.43–0.75]
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Figure 3: Receiver operating characteristic (ROC) curves of
procalcitonin (PCT) and C-reactive protein (CRP) testing on
admission for a conﬁrmed bacterial cause of fever in 157 travellers
who returned home with fever after a stay in the (sub)tropics.
The respective cutoﬀ points for CRP were 300, 250, 150, 100, and
50mg/L, respectively, and the cutoﬀ points for PCT were 10, 2, and
0.5ng/mL, respectively.
whereas speciﬁcity and NPV were 0.71 and 0.94, respectively
(data not shown).
4. Discussion/Conclusion
PCT has been used for more than a decade for the diagnosis,
monitoring of the course and severity of the systemic
inﬂammatory response syndrome (SIRS) observed during
severe infections [2–6]. We were particularly interested in
the accuracy of PCT for predicting a bacterial cause of
fever in a cohort of consecutive travellers who returned
home with fever. Although PCT levels above 2.0ng/mL
(corresponding with the class “moderate” or “high”) were
onlyseeninpatientswithdocumentedbacterialandparasitic
causative micro-organisms and in some patients allocated
to the group “likely infection”, respectively, the diagnostic
accuracy of PCT for bacterial infections was too poor to
advocate this semiquantitative PCT test for use in the initial
clinical evaluation of fever. At each cutoﬀ point of PCT, in
particularsensitivityandPPVweredisappointinglylow.This
assumption became also evident in the poor performance
of PCT in the ROC characteristics, where the performance
of PCT was not superior over measurement of C-reactive
protein. The conclusion that the diagnostic accuracy of PCT
for bacterial cause of fever is too low is also in line with
the observation made by others in other settings, such as
for the diagnosis of bacteremia in an emergency department
population [9].
The overall sensitivity of PCT for a bacterial cause of
fevercouldprobablybeimprovedifPCTwasmeasuredmore
precisely with an ultrasensitive PCT assay instead of the
semiquantitative assay used in this study. Although a direct
comparative study with a quantitative luminometric assay
demonstrated that, given a cutoﬀ value of 2.0ng/mL, the
majority of the semiquantitative PCT results were correctly
categorized [8], the ultrasensitive assays have the advantage
that they may accurately detect PCT concentrations of
0.1ng/mL and are capable of even measuring diﬀerences
in PCT levels in the range below 0.5ng/mL, the normal
range in our study [2, 4–6]. By using these ultrasensitive
assays, more subtle elevations of circulating PCT might
have been demonstrable, as may occur in more localized
bacterial infections. However, on the other hand, these
sensitive assays may have the relative disadvantage that
they are probably more time-consuming and laboratory-
dependent. In contrast, the semiquantitative PCT assay may
be performed at bedside or in the emergency room without
a need for further technical equipment or support and may
therefore be incorporated more easily in the initial clinical
assessment of a traveller with fever.
The poor diagnostic accuracy of PCT for identifying
bacterial causes of fever in our study may have resulted
from a relatively large group of patients with bacterial
infections of only limited severity, causing a local but
not a systemic inﬂammatory response. This suggestion is
supportedbytheﬁndingthatinpatientswhohadanelevated
PCT on admission, a higher body temperature—one of the
key contributors to SIRS—was documented, as compared
with patients with normal PCT levels. In fact, a signiﬁcant
relationship could be established between body temperature
on admission and PCT level, in particular in patients with
a documented bacterial cause of fever. In line with this,
in the 41 patients with a documented bacterial cause of
fever whom blood cultures were collected on admission,Interdisciplinary Perspectives on Infectious Diseases 7
increased PCT levels on admission were signiﬁcantly more
frequentlyseeninbacteremicpatientsthaninnonbacteremic
individuals, conﬁrming that systemic infections are indeed
a more powerful stimulus for PCT release than localized
infections.
Another limitation of our study may be the modest
prevalence (29.3%) of proven bacterial causes in our study,
which,ofcourse,directlyinﬂuencesthepositive andnegative
predictive values of PCT as a biomarker for bacterial cause
of fever. With the use of more sophisticated diagnostic
techniques like PCR, a causative bacterial micro-organism
might have been demonstrated in a subset of travellers now
allocated to the group “infection likely.” This would have
signiﬁcant impact on the discriminative power of PCT by
increasing the prevalence of proven bacterial infections in
our study. For example, the positive predictive value of PCT
(cutoﬀ point 0.5ng/mL) for a bacterial cause of fever would
have increased to 0.94 if all patients with a likely infection
wereassumedtohaveprovenbacterialinfection(Table 2(b)).
PCT appeared to be a biomarker with a rather high
speciﬁcity for bacterial infections as PCT levels were normal
in all but one patient with a documented viral cause of
fever. This observation is consistent with the ﬁndings of
Linscheid et al. [3] and may be explained by the fact that
interferon-gamma inhibits IL-1β-induced calcitonin mRNA
expression and PCT secretion [3]. Although speculative,
our data suggest that a PCT cutoﬀ point of 2.0ng/mL on
admission may safely exclude viral infections and ailments
due to noninfectious causes as a cause of fever in the ill-
returned traveller.
In conclusion, although an elevated PCT concentration
likely excludes viral causes of fever, the diagnostic accuracy
of this semiquantitative PCT test for a bacterial cause of
fever was too poor to advocate the use of this test in the
initialclinicalevaluationoffeverinasettingoftravellerswho
return home with fever after a stay in the (sub)tropics.
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